These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17875919)

  • 21. Relationship between CSF hypocretin levels and hypocretin neuronal loss.
    Gerashchenko D; Murillo-Rodriguez E; Lin L; Xu M; Hallett L; Nishino S; Mignot E; Shiromani PJ
    Exp Neurol; 2003 Dec; 184(2):1010-6. PubMed ID: 14769395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypocretin levels in sporadic and familial cases of canine narcolepsy.
    Ripley B; Fujiki N; Okura M; Mignot E; Nishino S
    Neurobiol Dis; 2001 Jun; 8(3):525-34. PubMed ID: 11442359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.
    Crocker A; España RA; Papadopoulou M; Saper CB; Faraco J; Sakurai T; Honda M; Mignot E; Scammell TE
    Neurology; 2005 Oct; 65(8):1184-8. PubMed ID: 16247044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke.
    Scammell TE; Nishino S; Mignot E; Saper CB
    Neurology; 2001 Jun; 56(12):1751-3. PubMed ID: 11425947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypocretin deficiency in familial symptomatic narcolepsy.
    Melberg A; Ripley B; Lin L; Hetta J; Mignot E; Nishino S
    Ann Neurol; 2001 Jan; 49(1):136-7. PubMed ID: 11198287
    [No Abstract]   [Full Text] [Related]  

  • 26. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.
    Knudsen S; Jennum PJ; Korsholm K; Sheikh SP; Gammeltoft S; Frederiksen JL
    Mult Scler; 2008 Jul; 14(6):734-8. PubMed ID: 18505777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypersomnolence and increased REM sleep with low cerebrospinal fluid hypocretin level in a patient after removal of craniopharyngioma.
    Tachibana N; Taniike M; Okinaga T; Ripley B; Mignot E; Nishino S
    Sleep Med; 2005 Nov; 6(6):567-9. PubMed ID: 16084764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posterior reversible encephalopathy syndrome (PRES): an unusual primary manifestation of a diffuse large B-cell lymphoma.
    Patejdl R; Borchert K; Pagumbke H; Benecke R; Grossmann A; Prall F; Kahl C; Freund M; Schmitt M; Walter U
    Clin Neurol Neurosurg; 2011 Nov; 113(9):819-21. PubMed ID: 21924823
    [No Abstract]   [Full Text] [Related]  

  • 29. HLA-DQB1 genotyping in a family with narcolepsy-cataplexy.
    Pedrazzoli M; Pontes JC; Peirano P; Tufik S
    Brain Res; 2007 Aug; 1165():1-4. PubMed ID: 17658488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders.
    Arii J; Kanbayashi T; Tanabe Y; Sawaishi Y; Kimura S; Watanabe A; Mishima K; Hishikawa Y; Shimizu T; Nishino S
    Neurology; 2004 Dec; 63(12):2440-2. PubMed ID: 15623725
    [No Abstract]   [Full Text] [Related]  

  • 31. [An old and new focal symptom, hypothalamus and hypersomnia, orexin system and narcolepsy].
    Kanbayashi T; Kondo H; Shimizu T; Nishino S
    Rinsho Shinkeigaku; 2005 Nov; 45(11):824-7. PubMed ID: 16447736
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of hypothalamic-specific autoimmunity in patients with narcolepsy.
    Martínez-Rodríguez JE; Sabater L; Graus F; Iranzo A; Santamaria J
    Sleep; 2007 Jan; 30(1):27-8. PubMed ID: 17310861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary central nervous system lymphoma in rheumatoid arthritis.
    Agrawal S; Singh YP; Kumari N; Kashyap R; Aggarwal A; Misra R
    J Clin Rheumatol; 2008 Feb; 14(1):54-5. PubMed ID: 18431104
    [No Abstract]   [Full Text] [Related]  

  • 34. Hypocretin (orexin) loss in Parkinson's disease.
    Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF
    Brain; 2007 Jun; 130(Pt 6):1577-85. PubMed ID: 17470494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Narcolepsy associated with primary temporal lobe B-cells lymphoma in a HLA DR2 negative subject.
    Onofrj M; Curatola L; Ferracci F; Fulgente T
    J Neurol Neurosurg Psychiatry; 1992 Sep; 55(9):852-3. PubMed ID: 1402982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients.
    Lodi R; Tonon C; Vignatelli L; Iotti S; Montagna P; Barbiroli B; Plazzi G
    Neurology; 2004 Oct; 63(8):1513-5. PubMed ID: 15505179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency.
    Knudsen S; Biering-Sørensen B; Kornum BR; Petersen ER; Ibsen JD; Gammeltoft S; Mignot E; Jennum PJ
    Neurology; 2012 Jul; 79(1):102-3. PubMed ID: 22722630
    [No Abstract]   [Full Text] [Related]  

  • 38. Narcolepsy in Parkinson's disease.
    Haq IZ; Naidu Y; Reddy P; Chaudhuri KR
    Expert Rev Neurother; 2010 Jun; 10(6):879-84. PubMed ID: 20518604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced hypothalamic gray matter in narcolepsy with cataplexy.
    Buskova J; Vaneckova M; Sonka K; Seidl Z; Nevsimalova S
    Neuro Endocrinol Lett; 2006 Dec; 27(6):769-72. PubMed ID: 17187022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypocretin measurement in an Icelandic foal with narcolepsy.
    Bathen-Nöthen A; Heider C; Fernandez AJ; Beineke A; Sewell AC; Otto M; Tipold A
    J Vet Intern Med; 2009; 23(6):1299-302. PubMed ID: 19909431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.